COSMOS Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
COSMOS Pharmaceutical has a total shareholder equity of ¥231.4B and total debt of ¥28.0B, which brings its debt-to-equity ratio to 12.1%. Its total assets and total liabilities are ¥476.5B and ¥245.1B respectively. COSMOS Pharmaceutical's EBIT is ¥31.0B making its interest coverage ratio 564.5. It has cash and short-term investments of ¥52.3B.
Key information
12.1%
Debt to equity ratio
JP¥27.97b
Debt
| Interest coverage ratio | 564.5x |
| Cash | JP¥52.30b |
| Equity | JP¥231.44b |
| Total liabilities | JP¥245.11b |
| Total assets | JP¥476.55b |
Recent financial health updates
Recent updates
An Intrinsic Calculation For COSMOS Pharmaceutical Corporation (TSE:3349) Suggests It's 41% Undervalued
Aug 17
COSMOS Pharmaceutical (TSE:3349) Will Want To Turn Around Its Return Trends
Aug 01Subdued Growth No Barrier To COSMOS Pharmaceutical Corporation's (TSE:3349) Price
Jun 28We Think COSMOS Pharmaceutical (TSE:3349) Can Stay On Top Of Its Debt
Jun 10COSMOS Pharmaceutical Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 17Some Shareholders Feeling Restless Over COSMOS Pharmaceutical Corporation's (TSE:3349) P/E Ratio
Mar 16Returns On Capital At COSMOS Pharmaceutical (TSE:3349) Paint A Concerning Picture
Feb 28Financial Position Analysis
Short Term Liabilities: 3349's short term assets (¥154.3B) do not cover its short term liabilities (¥213.2B).
Long Term Liabilities: 3349's short term assets (¥154.3B) exceed its long term liabilities (¥31.9B).
Debt to Equity History and Analysis
Debt Level: 3349 has more cash than its total debt.
Reducing Debt: 3349's debt to equity ratio has increased from 6.8% to 12.1% over the past 5 years.
Debt Coverage: 3349's debt is well covered by operating cash flow (197.3%).
Interest Coverage: 3349's interest payments on its debt are well covered by EBIT (564.5x coverage).